Marathon Digital Holdings Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details Narrative)

STOCKHOLDERS' EQUITY (Details Narrative)																1 Months Ended	3 Months Ended					9 Months Ended
STOCKHOLDERS' EQUITY (Details Narrative)	Sep. 21, 2015 USD ($) item $ / shares shares	Jul. 24, 2015 shares	Jan. 29, 2015 shares	Dec. 22, 2014 shares	Oct. 16, 2014 USD ($)	Oct. 06, 2014 shares	Sep. 30, 2014 USD ($) $ / shares shares	Sep. 16, 2014 shares	Jul. 18, 2014 shares	Jun. 30, 2014 USD ($) $ / shares shares	Jun. 02, 2014 shares	May. 02, 2014 USD ($) shares	Apr. 22, 2014 shares	Jun. 24, 2013	Oct. 01, 2012	Sep. 30, 2015 $ / shares shares	Sep. 30, 2015 USD ($) $ / shares shares	Jun. 30, 2015 shares	Mar. 31, 2015 shares	Dec. 31, 2014 $ / shares shares	Sep. 30, 2014 USD ($) $ / shares shares	Sep. 30, 2015 USD ($) $ / shares shares	Sep. 30, 2014 USD ($) $ / shares	Sep. 17, 2015 payment	Apr. 07, 2015 period	Sep. 17, 2014 shares	May. 01, 2014 shares	Jul. 18, 2013 $ / shares	Aug. 01, 2012 shares	Dec. 07, 2011 $ / shares shares	Dec. 06, 2011 $ / shares shares
Authorized shares of common stock																200,000,000	200,000,000			200,000,000		200,000,000								200,000,000	75,000,000
Common stock par value \| $ / shares																$ 0.0001	$ 0.0001			$ 0.0001		$ 0.0001						$ 0.0001		$ 0.0001	$ 0.001
Authorized shares of preferred stock																50,000,000	50,000,000			50,000,000		50,000,000								50,000,000
Preferred stock par value \| $ / shares																$ 0.0001	$ 0.0001			$ 0.0001		$ 0.0001								$ 0.0001
Increase in number of outstanding shares of common stock				6,895,730
Shares reserved for issuance under plan																													10,000,000
Reverse split														one (1) for thirteen (13)	3-for-2
Number of monthly installments \| period																									12
Issuance of Convertible Debt \| $					$ 5,550,000																	$ 19,600,000
Stock compensation expense, vested warrants \| $																	$ 556,205				$ 450,004	$ 1,971,323	$ 1,364,243
Common stock
Common stock issued			134,409								48,078
Shares issued upon exercise of options and warrants									26,722									33,968	5,000	29,230	84,652
Restricted Stock [Member]
Restricted shares issued							50,000	6,178		200,000			300,000
Fair value of restricted issuance \| $							$ 281,000			$ 980,000
Shares issued, value per share \| $ / shares							$ 5.62			$ 4.90											$ 5.62		$ 5.62
MedTech Development \| Common stock
Common stock issued		200,000
Consultants [Member] \| Common stock
Common stock issued	150,000
Stock Issued During Period, Value, Issued for Services \| $	$ 334,500
Value of stock issued \| $	$ 334,500
Shares issued, value per share \| $ / shares	$ 2.23
Number of consultants \| item	2
Consultant One Member \| Common stock
Common stock issued	90,000
Consultant Two [Member] \| Common stock
Common stock issued	60,000
Series B Preferred Stock [Member]
Authorized shares of preferred stock																											500,000
Preferred shares issued												782,000
Value, preferred shares and warrants issued \| $												$ 2,807,380
Series B Preferred Stock [Member] \| GRQ [Member]
Preferred shares agreement																										200,000
Percent vested upon execution of the GRQ Consulting Agreement																										50.00%
Percent vested after execution																										50.00%
Number of monthly installments \| payment																								(6)
Preferred Stock converted to Common Stock																183,330
Restricted shares issued						100,000